Hypocaloric Nutrition in Critically Ill Patients

NCT ID: NCT01531335

Last Updated: 2015-12-11

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-08-31

Study Completion Date

2012-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare two nutritional regimes in critically ill patients. Patients will be randomized to standard care (25 kcal per kg) or to hypocaloric nutrition (15 kcal per kg). The main outcome will be the SOFA (sequential organ failure assessment) score. The hypothesis is that hypocaloric hyperproteic diet decreases the incidence of organic failure in these patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The research site will be the intensive care unit (ICU) of Hospital Universitario San Ignacio; eligible patients will \>18 years of age with a presumed fasting period of at least 96 hours, with no contraindications for enteral nutrition. Patients with parenteral nutrition, pregnancy, diabetes, liver failure, renal failure, transplant protocol, or admitted from another hospital will be excluded. In all patients, the following information will be collected daily: enteral formula in ml, carbohydrate intake, insulin required (in IU), presence of hyper or hypoglicemia, presence of infections, among others.

The SOFA score will be assessed every two days until discharge from ICU.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critically Ill

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

adults

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard care

Patients will receive normal nutritional regime of around 25 kcal per kg.

Group Type ACTIVE_COMPARATOR

Standard care

Intervention Type DIETARY_SUPPLEMENT

25 kcal per kg of body weight

Hypocaloric hyperproteic nutrition

15 kcal per kg of body weight and 1.7 grams of protein per kg

Group Type EXPERIMENTAL

Hypocaloric hyperproteic nutrition

Intervention Type DIETARY_SUPPLEMENT

15 kcal per kg of body weight and 1.7 grams of protein per kg.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hypocaloric hyperproteic nutrition

15 kcal per kg of body weight and 1.7 grams of protein per kg.

Intervention Type DIETARY_SUPPLEMENT

Standard care

25 kcal per kg of body weight

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Hypocaloric hyperproteic Isocaloric

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \>18 years
* estimated fasting period of at least 96 hours

Exclusion Criteria

* parenteral nutrition
* pregnancy
* diabetes
* liver or renal failure
* transplantation
* admitted from another hospital
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Universitario San Ignacio

OTHER

Sponsor Role collaborator

Lafrancol S.A.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Saul Rugeles, MD

Role: PRINCIPAL_INVESTIGATOR

Pontificia Universidad Javeriana

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Universitario San Ignacio

Bogotá, DC, Colombia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Colombia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SJ0079

Identifier Type: -

Identifier Source: org_study_id